Neoleukin Therapeutics, Inc.
USD3.49
+0.05 (+1.45%)
CEO
Donna M. Cochener-Metcalfe
IPO Date
2014-03-07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$3.45
Prev. Close
$3.44
Day Low
$3.42
Day High
$3.59
52W Low
$3.42
52W High
$18.80
Market Cap
$0.01B
Volume
0.11M
| 31 Dec 2022 | FY | 0.0% | 0.0% | -61.0% | -49.6% | 0.13 | 8.96 | -0.5 |
| 31 Dec 2021 | FY | 100.0% | -1011533.3% | -42.5% | -37.2% | 0.09 | 16.67 | -4.4 |
| 31 Dec 2020 | FY | 100.0% | -7378.5% | -17.4% | -15.8% | 0.06 | 24.66 | -22.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -49.0% | -47.2% | 0.01 | 30.28 | -4.8 |
| 31 Dec 2018 | FY | 100.0% | -126.3% | -43.5% | -40.7% | 0.00 | 16.68 | -1.6 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -50.7% | -45.5% | 0.00 | 9.93 | -5.5 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -25.6% | -24.0% | 0.00 | 10.87 | -8.4 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -20.2% | -19.3% | 0.00 | 15.61 | -7.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -7.9% | -7.3% | 0.04 | 18.39 | -0.9 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -8.1% | -7.4% | 0.04 | 18.07 | -0.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -7.8% | -7.2% | 0.04 | 21.03 | -0.8 |
| 31 Dec 2024 | Q4 | 50.0% | -708.4% | -15.6% | -14.4% | 0.04 | 20.84 | -0.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -14.7% | -12.3% | 0.10 | 9.09 | -0.7 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -11.9% | -10.3% | 0.09 | 12.17 | -0.7 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -6.0% | -5.1% | 0.14 | 15.33 | -2.4 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -2.6% | -2.2% | 0.14 | 17.17 | -5.6 |